- $154.99m
- $173.66m
- $70.53m
FocalTherics slides after $40 million share sale
Brief: Focaltherics™ Announces Pricing Of Public Offering Of American Depositary Shares
Brief: Focaltherics™ Announces Proposed Public Offering Of American Depositary Shares
Edap Tms SA expected to post a loss of 20 cents a share - Earnings Preview
Brief: EDAP TMS Announces Corporate Name Change To FocalTherics
Brief: Telix Announces Collaborations To Explore Psma-Pet Imaging In Emerging Prostate Cancer Treatment Approaches
Brief: Edap Reports Strong Financial Results With Record First Quarter Hifu Revenue
France's EDAP TMS Q4 revenue beats on HIFU segment strength
Brief: EDAP Announces Preliminary Record Fourth Quarter And Full Year 2025 Hifu Revenue Issues 2026 Revenue Guidance
EDAP TMS Q3 revenue up 6%, beats estimates
Brief: EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU
Brief: EDAP Receives HIFU Reimbursement For Prostate Cancer In France
Edap Tms SA reports results for the quarter ended June 30 - Earnings Summary
Edap Tms SA expected to post a loss of 16 cents a share - Earnings Preview
Brief: Edap Tms SA To No Longer Qualify For Foreign Private Issuer Status Effective Jan 1, 2026
Edap Tms SA reports results for the quarter ended March 31 - Earnings Summary
Brief: Edap Reports First Quarter 2025 Financial Results
Edap Tms SA expected to post a loss of 15 cents a share - Earnings Preview
Edap Tms SA reports results for the quarter ended December 31 - Earnings Summary